A Comparative Study of Intrathecal Isobaric 0.5% Bupivacaine and Intrathecal Isobaric 0.75% Ropivacaine in Elective Lower Segment Cesarean Section

ABSTRACT

Objective: To compare the anesthetic efficacy of isobaric 0.75% ropivacaine with isobaric 0.5% bupivacaine in patients undergoing elective lower segment cesarean section (LSCS) under spinal anesthesia (SA) with respect to the nature of sensory block, motor block, and duration of analgesia. Materials and Methods: In this prospective, randomized, double‑blinded study, sixty full‑term parturients of American Society of Anesthesiologists Grade I–II, aged 20–35 years, scheduled for elective LSCS, were randomized into two groups namely B and R (n = 30). Preoperative medication regimen and anesthesia protocol followed, were uniform for all patients. Patients received 2.5 ml of either local anesthetic agent intrathecally. Hemodynamic parameters, onset and duration of sensory and motor blockade, level achieved, and side effects were compared between the two groups. Postoperative analgesia was assessed using the Visual Analog Scale scoring and also by noting the time of requirement of the first dose of rescue analgesic. Qualitative data were analyzed by Chi‑square test and quantitative data were analyzed by independent sample t‑test. Results: All the thirty patients in each arm completed the study without any dropouts. Baseline demographic variables, hemodynamic parameters, characteristics of sensory block (onset, time to reach peak sensory level, and duration), postoperative analgesia, and neonatal outcome were similar in both groups. However, intrathecal isobaric 0.75% ropivacaine demonstrated delayed onset (P = 0.005), and a significantly shorter duration (P = 0.001) of motor block. Conclusion: In view of the shorter duration of motor blockade, with similar duration of sensory blockade, hemodynamics, and postoperative analgesia, 0.75% isobaric ropivacaine (18.75 mg) is an efficient and safe alternative to bupivacaine for SA in elective LSCS.

KEYWORDS

• Cesarean section
• isobaric bupivacaine
• isobaric ropivacaine
• subarachnoid block

Showing references and in-text citations exactly as published.

Cite this article

• DOI10.4103/jpp.JPP_80_19Copy

RELATED ARTICLES

Matched on section and article type within this issue of J Pharmacol. Pharmacother..

• Article · VOLUME 10, ISSUE 4Online Videos as a Supplement Tool to Train II MBBS Students in Drug Administration SkillsSharmila V. Jalgaonkar, Raakhi K. Tripathi, Pankaj V. Sarkate, Santosh B. Salagre, Shobha M. Itolikar, Nirmala N. Rege · pp. 111–117Research PaperSame type: Article
• Article · VOLUME 10, ISSUE 4Assessment of Aromatase Inhibitor‑Induced Bone Loss and Appropriateness of Supportive Therapy in Postmenopausal Breast Cancer Patients at a Tertiary Care CenterRashmi Kumari, Emmanuel James, Wesley M. Jose · pp. 118–125Research PaperSame type: Article
• Article · VOLUME 10, ISSUE 4A Comparative Study between Sublingual Misoprostol (PGE1) versus Intracervical Dinoprostone Gel (PGE2) in the Induction of Labor:‑ A Prospective Observational StudyT.H. Deepika, H. Nagabushan, R. Manohar · pp. 132–137Research PaperSame type: Article